Refreshing results…
Sensitivity and Resistance of Oncogenic RAS-Driven Tumors to Dual MEK and ERK Inhibition
Download from doi.orgTargeting rare and non-canonical driver variants in NSCLC – an uncharted clinical field
UploadMetabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans
UploadMissing publications? Search for publications with a matching author name.